References
- Terry, A. V.; Buccafusco, J. The Cholinergic Hypothesis of Age and Alzheimer’s Disease-Related Cognitive Deficits: Recent Challenges and Their Implications for Novel Drug Development. J. Pharmacol. Exp. Ther. 2003, 306, 821–827. DOI: https://doi.org/10.1124/jpet.102.041616.
- Kumar, A.; Singh, A. A Review on Alzheimer’s Disease Pathophysiology and Its Management: An Update. Pharmacol. Rep. 2015, 67, 195–203. DOI: https://doi.org/10.1016/j.pharep.2014.09.004.
- World Health Organization. Demantia. https://www.who.int/news-room/fact-sheets/detail/dementia (Accessed September 19, 2019).
- Huang, Y.; Mucke, L. Alzheimer Mechanisms and Therapeutic Strategies. Cell 2012, 148, 1204–1222. DOI: https://doi.org/10.1016/j.cell.2012.02.040.
- Sugimoto, H.; Yamanishi, Y.; Iimura, Y.; Kawakami, Y. Donepezil Hydrochloride (E2020) and Other Acetylcholinesterase Inhibitors. Curr. Med. Chem. 2000, 7, 303–339. DOI: https://doi.org/10.2174/0929867003375191.
- Trujillo-Ferrara, J.; Montoya Cano, L.; Espinoza-Fonseca, M. Synthesis, Anticholinesterase Activity and Structure–Activity Relationships of m-Aminobenzoic Acid Derivatives. Bioorg. Med. Chem. Lett. 2003, 13, 1825–1827. DOI: https://doi.org/10.1016/S0960-894X(03)00198-7.
- Selkoe, D. J. Alzheimer’s Disease: Genes, Proteins, and Therapy. Physiol. Rev. 2001, 81, 741–766. DOI: https://doi.org/10.1152/physrev.2001.81.2.741.
- Weinstock, M.; Groner, E. Rational Design of a Drug for Alzheimer’s Disease with Cholinesterase Inhibitory and Neuroprotective Activity. Chem. Biol. Interact. 2008, 175, 216–221. DOI: https://doi.org/10.1016/j.cbi.2008.03.014.
- Cummings, J. L.; Doody, R.; Clark, C. Disease-Modifying Therapies for Alzheimer Disease: Challenges to Early Intervention. Neurology 2007, 69, 1622–1634. DOI: https://doi.org/10.1212/01.wnl.0000295996.54210.69.
- Liston, D. R.; Nielsen, J. A.; Villalobos, A.; Chapin, D.; Jones, S. B.; Hubbard, S. T.; Shalaby, I. A.; Ramirez, A.; Nason, D.; White, W. F. Pharmacology of Selective Acetylcholinesterase Inhibitors: Implications for Use in Alzheimer’s Disease. Eur. J. Pharmacol. 2004, 486, 9–17. DOI: https://doi.org/10.1016/j.ejphar.2003.11.080.
- Mustazza, C.; Borioni, A.; Del Giudice, M. R.; Gatta, F.; Ferretti, R.; Meneguz, A.; Volpe, M. T.; Lorenzini, P. Synthesis and Cholinesterase Activity of Phenylcarbamates Related to Rivastigmine, a Therapeutic Agent for Alzheimer’s Disease. Eur. J. Med. Chem. 2002, 37, 91–109. DOI: https://doi.org/10.1016/S0223-5234(01)01324-1.
- Cygler, M.; Schrag, J. D.; Sussman, J. L.; Harel, M.; Silman, I.; Gentry, M. K.; Doctor, B. P. Relationship between Sequence Conservation and Three-Dimensional Structure in a Large Family of Esterases, Lipases, and Related Proteins. Protein Sci. 1993, 2, 366–382. DOI: https://doi.org/10.1002/pro.5560020309.
- Razavi, S. F.; Khoobi, M.; Nadri, H.; Sakhteman, A.; Moradi, A.; Emami, S.; Foroumadi, A.; Shafiee, A. Synthesis and Evaluation of 4-Substituted Coumarins as Novel Acetylcholinesterase Inhibitors. Eur. J. Med. Chem. 2013, 64, 252–259. DOI: https://doi.org/10.1016/j.ejmech.2013.03.021.
- Khan, M. T. H. Molecular Interactions of Cholinesterases Inhibitors Using in Silico Methods: Current Status and Future Prospects. N. Biotechnol. 2009, 5, 331–346. DOI: https://doi.org/10.1016/j.nbt.2009.03.008.
- Zhang, J.; Zhu, D.; Sheng, R.; Wu, H.; Hu, Y.; Wang, F.; Cai, T.; Yang, B.; He, Q. BZYX, a Novel Acetylcholinesterase Inhibitor, Significantly Improved Chemicals-Induced Learning and Memory Impairments on Rodents and Protected PC12 Cells from Apoptosis Induced by Hydrogen Peroxide. Eur. J. Pharmacol. 2009, 613, 1–9. DOI: https://doi.org/10.1016/j.ejphar.2009.03.054.
- Nukoolkarn, S. V.; Saen-Oon, S.; Rungrotmongkol, T.; Hannongbua, S.; Ingkaninan, K.; Suwanborirux, K. Petrosamine, a Potent Anticholinesterase Pyridoacridine Alkaloid from a Thai Marine Sponge Petrosia n. sp. Bioorg. Med. Chem. 2008, 16, 6560–6567. DOI: https://doi.org/10.1016/j.bmc.2008.05.027.
- Mukherjee, P. K.; Kumar, V.; Mal, M.; Houghton, P. J. Acetylcholinesterase Inhibitors from Plants. Phytomedicine 2007, 14, 289–300. DOI: https://doi.org/10.1016/j.phymed.2007.02.002.
- Silman, L.; Sussman, J. L. Acetylcholinesterase: ‘Classical’ and ‘Non-Classical’ Functions and Pharmacology. Curr. Opin. Pharmacol. 2005, 5, 293–302. DOI: https://doi.org/10.1016/j.coph.2005.01.014.
- Bullock, R.; Dengiz, A. Cognitive Performance in Patients with Alzheimer’s Disease Receiving Cholinesterase Inhibitors for up to 5 Years. Int. J. Clin. Pract. 2005, 59, 817–822. DOI: https://doi.org/10.1111/j.1368-5031.2005.00562.x.
- Racchi, M.; Mazzucchelli, M.; Porrello, E.; Lanni, C.; Govoni, S. Acetylcholinesterase Inhibitors: Novel Activities of Old Molecules. Pharmacol. Res. 2004, 50, 441–451. DOI: https://doi.org/10.1016/j.phrs.2003.12.027.
- Ibrar, A.; Khan, A.; Ali, M.; Sarwar, R.; Mehsud, S.; Farooq, U.; Halimi, S.; Khan, I.; Al-Harrasi, A. Combined in Vitro and in Silico Studies for the Anticholinesterase Activity and Pharmacokinetics of Coumarinyl Thiazoles and Oxadiazoles. Front. Chem. 2018, 6, 61. DOI: https://doi.org/10.3389/fchem.2018.00061.
- Rodda, J.; Carter, J. Cholinesterase Inhibitors and Memantine for Symptomatic Treatment of dementia. BMJ 2012, 344, e2986. DOI: https://doi.org/10.1136/bmj.e2986.
- Haroun, M.; Tratrat, C.; Tsolaki, E.; Geronikaki, A. Thiazole-Based Thiazolidinones as Potent Antimicrobial Agents. Design, Synthesis and Biological Evaluation. Comb. Chem. High Throughput Screen. 2016, 19, 51–57. DOI: https://doi.org/10.2174/1386207319666151203002348.
- Rostom, S. A.; El-Ashmawy, I. M.; Abd El Razik, H. A.; Badr, M. H.; Ashour, H. M. Design and Synthesis of Some Thiazolyl and Thiadiazolyl Derivatives of Antipyrine as Potential Non-Acidic Anti-Inflammatory, Analgesic and Antimicrobial Agents. Bioorg. Med. Chem. 2009, 17, 882–895. DOI: https://doi.org/10.1016/j.bmc.2008.11.035.
- Luzina, E. L.; Popov, A. V. Synthesis and Anticancer Activity of N-Bis(Trifluoromethyl)Alkyl-N'-Thiazolyl and N-Bis(Trifluoromethyl)Alkyl-N'-Benzothiazolyl Ureas. Eur. J. Med. Chem. 2009, 44, 4944–4953. DOI: https://doi.org/10.1016/j.ejmech.2009.08.007.
- Turan-Zitouni, G.; Chevallet, P.; Kilic, F. S.; Erol, K. Synthesis of Some Thiazolyl-Pyrazoline Derivatives and Preliminary Investigation of Their Hypotensive Activity. Eur. J. Med. Chem. 2000, 35, 635–641. DOI: https://doi.org/10.1016/S0223-5234(00)00152-5.
- Zablotskaya, A.; Segal, I.; Germane, S.; Shestakova, I.; Domracheva, I.; Nesterova, A.; Geronikaki, A.; Lukevics, E. Silyl Modification of Biologically Active Compounds. 8. Trimethylsilyl Ethers of Hydroxyl-Containing Thiazole Derivatives. Chem. Heterocycl. Compd. 2002, 38, 859–866. . DOI: https://doi.org/10.1023/A:1020698107686.
- Britschgi, M.; Greyerz, S.; Burkhart, C.; Pichler, W. J. Molecular Aspects of Drug Recognition by Specific T Cells. Curr. Drug Targets 2003, 4, 1–11. DOI: https://doi.org/10.2174/1389450033347082.
- Mohsen, U. A.; Kaplancikli, Z. A.; Özkay, Y.; Yurttaş, L. Synthesis and Evaluation of anti-Acetylcholinesterase Activity of Some Benzothiazole Based New Piperazine-Dithiocarbamate Derivatives. Drug Res. 2015, 65, 176–183. DOI: https://doi.org/10.1055/s-0034-1375613.
- Yin, L.; Cheng, F. C.; Li, Q. X.; Liu, W. W.; Liu, X. J.; Cao, Z. L.; Shi, D. H. Synthesis and Biological Evaluation of Novel C1-Glycosyl Thiazole Derivatives as Acetylcholinesterase Inhibitors. J. Chem. Res. 2016, 40, 545–548. DOI: https://doi.org/10.3184/174751916X14711768865726.
- Wang, Y. X.; Liu, S. H.; Shao, Z. B.; Cao, L. G.; Jiang, K. J.; Lu, X.; Wang, L.; Liu, W. W.; Shi, D. H.; Cao, Z. L. Synthesis and Anti-Acetylcholinesterase Activities of Novel Glycosyl Coumarylthiazole Derivatives. J. Chem. Res. 2021, 2021, 359–364. DOI: https://doi.org/10.1177/1747519820948358.
- Ibrar, A.; Zaib, S.; Khan, I.; Jabeen, F.; Iqbal, J.; Saeed, A. Facile and Expedient Access to Bis-Coumarin–Iminothiazole Hybrids by Molecular Hybridization Approach: Synthesis, Molecular Modelling and Assessment of Alkaline Phosphatase Inhibition, Anticancer and Antileishmanial Potential. RSC Adv. 2015, 5, 89919–89931. DOI: https://doi.org/10.1039/C5RA14900B.
- Tehrani, M. B.; Rezaei, Z.; Asadi, M.; Behnammanesh, H.; Nadri, H.; Afsharirad, F.; Moradi, A.; Larijani, B.; Mohammadi‐Khanaposhtani, M.; Mahdavi, M. Design, Synthesis, and Cholinesterase Inhibition Assay of Coumarin-3-carboxamide-N-morpholine Hybrids as New Anti-Alzheimer Agents. Chem. Biodivers. 2019, 16, e1900144. DOI: https://doi.org/10.1002/cbdv.201900144.
- Can, N. Ö.; Çevik, U. A.; Sağlık, B. N.; Özkay, Y.; Atlı, Ö.; Baysal, M.; Özkay, Ü. D.; Can, Ö. D. Pharmacological and Toxicological Screening of Novel Benzimidazole-Morpholine Derivatives as Dual-Acting Inhibitors. Molecules 2017, 22, 1374. DOI: https://doi.org/10.3390/molecules22081374.
- Soyer, Z.; Uysal, S.; Parlar, S.; Dogan, A. H. T.; Alptuzun, V. Synthesis and Molecular Docking Studies of Some 4-Phthalimidobenzenesulfonamide Derivatives as Acetylcholinesterase and Butyrylcholinesterase Inhibitors. J. Enzyme Inhib. Med. Chem. 2017, 32, 13–19. DOI: https://doi.org/10.1080/14756366.2016.1226298.
- Mehrabi, F.; Pourshojaei, Y.; Moradi, A.; Sharifzadeh, M.; Khosravani, L.; Sabourian, R.; Rahmani-Nezhad, S.; Mohammadi-Khanaposhtani, M.; Mahdavi, M.; Asadipour, A.; et al. Design, Synthesis, Molecular Modeling and Anticholinesterase Activity of Benzylidene-Benzofuran-3-Ones Containing Cyclic Amine Side Chain. Future Med. Chem. 2017, 9, 659–671. DOI: https://doi.org/10.4155/fmc-2016-0237.
- Yang, Q.; Ulysse, L. G.; McLaws, M. D.; Keefe, D. K.; Haney, B. P.; Zha, C.; Guzzo, P. R.; Liu, S. Initial Process Development and Scale-Up of the Synthesis of a Triple Reuptake Inhibitor ALB 109780. Org. Process Res. Dev. 2012, 16, 499–506. DOI: https://doi.org/10.1021/op3000064.
- Xu, W.; Gray, D. L.; Glase, S. A.; Barta, N. S. Design and Synthesis of Reboxetine Analogs Morpholine Derivatives as Selective Norepinephrine Reuptake Inhibitors. Bioorg. Med. Chem. Lett. 2008, 18, 5550–5553. DOI: https://doi.org/10.1016/j.bmcl.2008.09.007.
- Chrysselis, M. C.; Rekka, E. A.; Siskou, I. C.; Kourounakis, P. N. Nitric Oxide Releasing Morpholine Derivatives as Hypolipidemic and Antioxidant Agents. J. Med. Chem. 2002, 45, 5406–5409. DOI: https://doi.org/10.1021/jm011062i.
- Burland, P. A.; Osborn, H. M. I.; Turkson, A. Synthesis and Glycosidase Inhibitory Profiles of Functionalised Morpholines and Oxazepanes. Bioorg. Med. Chem. 2011, 19, 5679–5692. DOI: https://doi.org/10.1016/j.bmc.2011.07.019.
- Sanad, S. M. H.; Mekky, A. E. M.; El-Reedy, A. A. M. Tandem Synthesis and Antibacterial Screening of Novel Thieno[2,3-b]Thiophene-Linked Bis(Thiazole) Hybrids. Synth. Commun. 2021, 51, 1982–1993. DOI: https://doi.org/10.1080/00397911.2021.1918170.
- Sanad, S. M. H.; Mekky, A. E. M.; Said, A. Y.; Elneairy, M. A. A. Pyridine-2(1H)-Thiones: Versatile Precursors for One-Pot Synthesis of New Nicotinonitrile-Thiazole Hybrids. J. Heterocyclic Chem. 2021, 58, 1461–1471. DOI: https://doi.org/10.1002/jhet.4272.
- Sanad, S. M. H.; Mekky, A. E. M.; Said, A. Y.; Elneairy, M. A. A. New Thieno[2,3-b]Pyridine-Fused [1,2,4]Triazolo[4,3-a] Pyrimidinone Hybrids as Potential MRSA and VRE Inhibitors. Mendeleev Commun. 2021, 31, 370–372. DOI: https://doi.org/10.1016/j.mencom.2021.04.029.
- Sanad, S. M. H.; Mekky, A. E. M. Synthesis, in-Vitro Antibacterial and Anticancer Screening of Novel Nicotinonitrile-Coumarin Hybrids Utilizing Piperazine Citrate. Synth. Commun. 2020, 50, 1468–1485. DOI: https://doi.org/10.1080/00397911.2020.1743318.
- Ahmed, A. A. M.; Mekky, A. E. M.; Elwahy, A. H. M.; Sanad, S. M. H. Facile Synthesis and Characterization of Novel Benzo-Fused Macrocyclic Dicarbonitriles and Pyrazolo-Fused Macrocycles Containing Thiazole Subunits. Synth. Commun. 2020, 50, 796–804. DOI: https://doi.org/10.1080/00397911.2019.1689269.
- Hawass, M. A. E.; Sanad, S. M. H.; Elwahy, A. H. M.; Abdelhamid, I. A. Hantzsch Synthesis of Bis(Pyrido[2,3-d:6,5-d']Dipyrimidines), Bis(Pyrimido[4,5-b]Quinolines), and Bis(Benzo[4,5]Imidazo[2,1-b]Quinazolines) Linked to Pyrazole Units as Novel Hybrid Molecules. Synth. Commun. 2021, 51, 1899–1912. DOI: https://doi.org/10.1080/00397911.2021.1913604.
- Mekky, A. E. M.; Sanad, S. M. H. Novel Bis(Pyrazole-Benzofuran) Hybrids Possessing Piperazine Linker: Synthesis of Potent Bacterial Biofilm and MurB Inhibitors. Bioorg. Chem. 2020, 102, 104094. DOI: https://doi.org/10.1016/j.bioorg.2020.104094.
- Mohamed Teleb, M. A.; Mekky, A. E. M.; Sanad, S. M. H. 3-Aminothieno[2,3-b]Pyridine-2-Carboxylate: Effective Precursor for Microwave Assisted Three Components Synthesis of New Pyrido[3',2':4,5]Thieno[3,2-d]Pyrimidin-4(3H)-One Hybrids. J. Heterocyclic Chem. 2021, DOI: https://doi.org/10.1002/jhet.4313..
- Sanad, S. M. H.; Ahmed, M. S. M.; Mekky, A. E. M.; Abdallah, Z. A. Regioselective Synthesis and Theoretical Calculations of Bis(Pyrido[2',3':3,4]Pyrazolo[1,5-a]Pyrimidines) Linked to Benzofuran Units via Piperazine Spacer: A DFT, MM2, and MMFF94 Study. J. Mol. Struct. 2021, 1243, 130802. DOI: https://doi.org/10.1016/j.molstruc.2021.130802.
- Sanad, S. M. H.; Mekky, A. E. M. New Pyrido[3',2':4,5]Thieno[3,2-d]Pyrimidin-4(3H)-One Hybrids Linked to Arene Units: Synthesis of Potential MRSA, VRE and COX-2 Inhibitors. Can. J. Chem. 2021, DOI: https://doi.org/10.1139/cjc-2021-0121.
- Mekky, A. E. M.; Sanad, S. M. H. Synthesis, Characterization, and Antimicrobial Evaluation of Novel Thiohydrazonates and Pyrazolo[3,4-b]Pyridines. Polycycl. Aromat. Compd. 2021, 41, 936–949. DOI: https://doi.org/10.1080/10406638.2019.1631194.
- Sanad, S. M. H.; Mekky, A. E. M. Enaminone Incorporating a Dibromobenzofuran Moiety: Versatile Precursor for Novel Azines and Azolotriazines. J. Heterocyclic Chem. 2018, 55, 836–843. DOI: https://doi.org/10.1002/jhet.3107.
- Abdelhamid, I. A.; Hawass, M. A. E.; Sanad, S. M. H.; Elwahy, A. H. M. Synthesis of Various Pyrazole-Fused Heterocyclic Systems Using Pyrazole-4-Carbaldehydes as Versatile Precursors. Arkivoc 2021, 2021(ix), 42–74. DOI: https://doi.org/10.24820/ark.5550190.p011.542.
- Shaker, M.; Beni, A. S. Cu@SB-MCM-41 Composite as an Efficient and Recyclable Nanocatalyst for the Synthesis of Polyhydroquinoline Derivatives via Unsymmetrical Hantzsch Reaction. J. Porous Mater. 2021, 28, 435–449. DOI: https://doi.org/10.1007/s10934-020-01006-8.
- Guieu, S.; Rocha, J.; Silva, A. M. Synthesis of Unsymmetrical Methylenebisphenol Derivatives. Synlett 2013, 24, 762–764. DOI: https://doi.org/10.1055/s-0032-1318394.
- Mishra, R.; Panday, A. K.; Choudhury, L. H.; Pal, J.; Subramanian, R.; Verma, A. Multicomponent Reactions of Arylglyoxal, 4-Hydroxycoumarin, and Cyclic 1,3-C,N-Binucleophiles: Binucleophile-Directed Synthesis of Fused Five- and Six-Membered N-Heterocycles. Eur. J. Org. Chem. 2017, 2017, 2789–2800. DOI: https://doi.org/10.1002/ejoc.201700115.
- Li, L.; Xu, H.; Dai, L.; Xi, J.; Gao, L.; Rong, L. An Efficient Metal-Free Cascade Process for the Synthesis of 4-Arylpyrimido[1,2-b]Indazole-3-Carbonitrile Derivatives. Tetrahedron 2017, 73, 5358–5365. DOI: https://doi.org/10.1016/j.tet.2017.07.035.
- Ibarra, I. A.; Islas-Jácome, A.; González-Zamora, E. Synthesis of Polyheterocycles via Multicomponent Reactions. Org. Biomol. Chem. 2018, 16, 1402–1418. DOI: https://doi.org/10.1039/c7ob02305g.
- Dey, S.; Lo, H. J.; Wong, C. H. Programmable One-Pot Synthesis of Heparin Pentasaccharide Fondaparinux. Org. Lett. 2020, 22, 4638–4642. DOI: https://doi.org/10.1021/acs.orglett.0c01386.
- Dey, S.; Lo, H. J.; Wong, C. H. An Efficient Modular One-Pot Synthesis of Heparin-Based Anticoagulant Idraparinux. J. Am. Chem. Soc. 2019, 141, 10309–10314. DOI: https://doi.org/10.1021/jacs.9b03266.
- Dey, S.; Wong, C. H. Programmable One-Pot Synthesis of Heparin Pentasaccharides Enabling Access to Regiodefined Sulfate Derivatives. Chem. Sci. 2018, 9, 6685–6691. DOI: https://doi.org/10.1039/c8sc01743c.
- Sanad, S. M. H.; Ahmed, A. A. M.; Mekky, A. E. M. Synthesis, in-Vitro and in-Silico Study of Novel Thiazoles as Potent Antibacterial Agents and MurB Inhibitors. Arch. Pharm. 2020, 353, e1900309. DOI: https://doi.org/10.1002/ardp.201900309.
- Mekky, A. E. M.; Sanad, S. M. H. Microwave Assisted Synthesis of Novel Bis(Thiazoles) Incorporating Piperazine Moiety. J. Heterocyclic Chem. 2019, 56, 1560–1566. DOI: https://doi.org/10.1002/jhet.3531.
- Ellman, G. L.; Courtney, K. D.; Andres, V.; Feather-Stone, R. M. A New and Rapid Colorimetric Determination of Acetylcholinesterase Activity. Biochem. Pharmacol. 1961, 7, 88–90. DOI: https://doi.org/10.1016/0006-2952(61)90145-9.
- Mekky, A. E. M.; Sanad, S. M. H. Synthesis and in Vitro Study of New Coumarin Derivatives Linked to Nicotinonitrile Moieties as Potential Acetylcholinesterase Inhibitors. J. Heterocyclic Chem. 2020, 57, 4278–4290. DOI: https://doi.org/10.1002/jhet.4134.
- Alipour, M.; Khoobi, M.; Foroumadi, A.; Nadri, H.; Moradi, A.; Sakhteman, A.; Ghandi, M.; Shafiee, A. Novel Coumarin Derivatives Bearing N-Benzyl Pyridinium Moiety: Potent and Dual Binding Site Acetylcholinesterase Inhibitors. Bioorg. Med. Chem. 2012, 20, 7214–7222. DOI: https://doi.org/10.1016/j.bmc.2012.08.052.
- Feng, Y.; Wang, X. Antioxidant Therapies for Alzheimer’s Disease. Oxid. Med. Cell. Longev. 2012, 2012, 472932. DOI: https://doi.org/10.1155/2012/472932.
- Aliev, G.; Obrenovich, M. E.; Reddy, V. P.; Shenk, J. C.; Moreira, P. I.; Nunomura, A.; Zhu, X.; Smith, M. A.; Perry, G. Antioxidant Therapy in Alzheimer’s Disease: Theory and Practice. Mini Rev. Med. Chem. 2008, 8, 1395–1406. DOI: https://doi.org/10.2174/138955708786369582.
- Frank, B.; Gupta, S. A Review of Antioxidants and Alzheimer’s Disease. Ann. Clin. Psychiatry 2005, 17, 269–286. DOI: https://doi.org/10.3109/10401230500296428.
- McLellan, M. E.; Kajdasz, S. T.; Hyman, B. T.; Bacskai, B. J. In Vivo Imaging of Reactive Oxygen Species Specifically Associated with Thioflavine S-Positive Amyloid Plaques by Multiphoton Microscopy. J. Neurosci. 2003, 23, 2212–2217. DOI: https://doi.org/10.1523/JNEUROSCI.23-06-02212.2003.
- Sanad, S. M. H.; Mekky, A. E. M. Novel Nicotinonitrile-Coumarin Hybrids as Potential Acetylcholinesterase Inhibitors: Design, Synthesis, in Vitro and in Silico Studies. J. Iran. Chem. Soc. 2021, 18, 213–224. DOI: https://doi.org/10.1007/s13738-020-02018-6.